Brooke M. Pancoe - 28 Jan 2026 Form 4 Insider Report for ARROW FINANCIAL CORP (AROW)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Feb 2026, 16:45:27 UTC
Prior SEC filing
03 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Penko Ivanov, Attorney in Fact

Key filing fact

Brooke M. Pancoe filed Form 4 for ARROW FINANCIAL CORP (AROW) on 02 Feb 2026.

Key facts

  • This page summarizes Brooke M. Pancoe's Form 4 filing for ARROW FINANCIAL CORP (AROW).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Feb 2026, 16:45.

Change

  • Previous filing in this sequence was filed on 03 Feb 2025.
  • Current net transaction value: +$78,027.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002017645 Primary reporting owner

Pancoe Brooke M

Relationship
EVP, Chief HR Officer
Address
250 GLEN STREET, GLENS FALLS
Signature
Penko Ivanov, Attorney in Fact
Signature date
02 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AROW transaction

Common Stock

Award

Transaction value
$78,027
Shares
+2,406
Change %
+51%
Price
$32.43
Shares after
7,145
Date
28 Jan 2026
Ownership
Direct
Footnotes
F1, F2
AROW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25
Date
28 Jan 2026
Ownership
Held by spounse
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The restricted stock vests 25% per year on January 28, 2027, January 28, 2028, January 28, 2029, and January 28, 2030.

Footnote F2

The information provided reflects an increase of 1,775 shares related to the 2024 ESOP allocation.

Footnote F3

The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for any purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .